G-Lucas Summary

A randomized, placebo-controlled, multicenter phase-II-study to investigate the protectivity and efficacy of metformin in combination with FOLFIRI and cetuximab in patients with previously untreated, KRAS-wild-type, metastatic colorectal cancer

Start: 04/2012
Coordinating investigator: Gr├╝nberger, Birgit; Vienna
Sample size: 132
Design:
(Click to enlarge)
G-Lucas Design